A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation
Venous thromboembolism (VTE) is a life-threatening complication, especially in case of recurrence. The appropriate duration of anticoagulant treatment following the first event is crucial. Risk factors that increase the risk of recurrence of VTE are many, and include medications, kidney disease, ren...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-07-01
|
| Series: | Thalassemia Reports |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2039-4365/12/3/13 |
| _version_ | 1797481885319823360 |
|---|---|
| author | Rosario Di Maggio Alessandra Giuliano Disma Renda Giuseppina Calvaruso Simona Raso Lorella Pitrolo Antonio Carroccio Aurelio Maggio |
| author_facet | Rosario Di Maggio Alessandra Giuliano Disma Renda Giuseppina Calvaruso Simona Raso Lorella Pitrolo Antonio Carroccio Aurelio Maggio |
| author_sort | Rosario Di Maggio |
| collection | DOAJ |
| description | Venous thromboembolism (VTE) is a life-threatening complication, especially in case of recurrence. The appropriate duration of anticoagulant treatment following the first event is crucial. Risk factors that increase the risk of recurrence of VTE are many, and include medications, kidney disease, renal transplantation (RT), and a diagnosis of sickle cell disease (SCD). There are currently no guidelines that define the duration of anticoagulant therapy after the first event in a patient with RT. We report a case of recurring episodes of VTE after RT in a SCD patient. Our case suggests that the use of a long-term anticoagulant treatment may be recommended in patients with SCD and RT after the first event of VTE. |
| first_indexed | 2024-03-09T22:20:57Z |
| format | Article |
| id | doaj.art-3309d480ed2341b8b0c4ec40bc7230af |
| institution | Directory Open Access Journal |
| issn | 2039-4365 |
| language | English |
| last_indexed | 2024-03-09T22:20:57Z |
| publishDate | 2022-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Thalassemia Reports |
| spelling | doaj.art-3309d480ed2341b8b0c4ec40bc7230af2023-11-23T19:14:21ZengMDPI AGThalassemia Reports2039-43652022-07-01123858910.3390/thalassrep12030013A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal TransplantationRosario Di Maggio0Alessandra Giuliano1Disma Renda2Giuseppina Calvaruso3Simona Raso4Lorella Pitrolo5Antonio Carroccio6Aurelio Maggio7Campus of Hematology “Franco e Piera Cutino”, V. Cervello Hospital, 90146 Palermo, ItalyInternal Medicine Unit, V. Cervello Hospital, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90133 Palermo, ItalyCampus of Hematology “Franco e Piera Cutino”, V. Cervello Hospital, 90146 Palermo, ItalyCampus of Hematology “Franco e Piera Cutino”, V. Cervello Hospital, 90146 Palermo, ItalyCampus of Hematology “Franco e Piera Cutino”, V. Cervello Hospital, 90146 Palermo, ItalyCampus of Hematology “Franco e Piera Cutino”, V. Cervello Hospital, 90146 Palermo, ItalyInternal Medicine Unit, V. Cervello Hospital, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90133 Palermo, ItalyCampus of Hematology “Franco e Piera Cutino”, V. Cervello Hospital, 90146 Palermo, ItalyVenous thromboembolism (VTE) is a life-threatening complication, especially in case of recurrence. The appropriate duration of anticoagulant treatment following the first event is crucial. Risk factors that increase the risk of recurrence of VTE are many, and include medications, kidney disease, renal transplantation (RT), and a diagnosis of sickle cell disease (SCD). There are currently no guidelines that define the duration of anticoagulant therapy after the first event in a patient with RT. We report a case of recurring episodes of VTE after RT in a SCD patient. Our case suggests that the use of a long-term anticoagulant treatment may be recommended in patients with SCD and RT after the first event of VTE.https://www.mdpi.com/2039-4365/12/3/13thromboemolismrenal transplantationsickle cellanticoagulation |
| spellingShingle | Rosario Di Maggio Alessandra Giuliano Disma Renda Giuseppina Calvaruso Simona Raso Lorella Pitrolo Antonio Carroccio Aurelio Maggio A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation Thalassemia Reports thromboemolism renal transplantation sickle cell anticoagulation |
| title | A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation |
| title_full | A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation |
| title_fullStr | A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation |
| title_full_unstemmed | A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation |
| title_short | A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation |
| title_sort | patient with sickle cell disease and recurrent venous thromboembolism after renal transplantation |
| topic | thromboemolism renal transplantation sickle cell anticoagulation |
| url | https://www.mdpi.com/2039-4365/12/3/13 |
| work_keys_str_mv | AT rosariodimaggio apatientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT alessandragiuliano apatientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT dismarenda apatientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT giuseppinacalvaruso apatientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT simonaraso apatientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT lorellapitrolo apatientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT antoniocarroccio apatientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT aureliomaggio apatientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT rosariodimaggio patientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT alessandragiuliano patientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT dismarenda patientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT giuseppinacalvaruso patientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT simonaraso patientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT lorellapitrolo patientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT antoniocarroccio patientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation AT aureliomaggio patientwithsicklecelldiseaseandrecurrentvenousthromboembolismafterrenaltransplantation |